Brazil Drug Industry Frets Pricing Formula Delay Could Cause Problems
This article was originally published in PharmAsia News
Executive Summary
Drug makers in Brazil are raising concerns about the government's uncharacteristic delay in publishing how it has calculated new price caps for medicines sold in the country.